Cutler Capital Management, LLC Exelixis, Inc. Transaction History

Cutler Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$14.46 - $21.8 $144,600 - $218,000	-10,000 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$15.15 - $18.89 $37,875 - $47,225	-2,500 Reduced 20.0%	10,000 $176,000
Q1 2019 Apr 30, 2019	BUY	$19.6 - $24.76 $29,400 - $37,140	1,500 Added 13.64%	12,500 $297,000
Q4 2018 Jan 25, 2019	BUY	$13.65 - $21.8 $13,650 - $21,800	1,000 Added 10.0%	11,000 $216,000
Q1 2018 May 08, 2018	SELL	$22.15 - $31.89 $443,000 - $637,800	-20,000 Reduced 66.67%	10,000 $221,000

Q3 2017 Nov 13, 2017	BUY	$23.35 - $29.24 $700,500 - $877,200	30,000	30,000 $727,000

460

246M

1.7M

1.02M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Cutler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cutler Capital Management, LLC with notifications on news.